Interacciones farmacocinéticas de la azitromicina e implicación clínica

Translated title of the contribution: Pharmacokinetic interactions of azithromycin and clinical implication

María Saravia Bartra, Ricardo Losno García, Milton Valderrama-Wong, Ana María Muñoz Jáuregui, María Bendezú Acevedo, Jorge García Ceccarelli, Felipe Surco Laos, Patricia Basurto Ayala, Mario Pineda-Pérez, Angel Tito Alvarado Yarasca

Research output: Contribution to journalArticlepeer-review

Abstract

Introduction: The severe acute respiratory syndrome (due to COVID-19) is currently the leading cause of death in Peru, so effective and safe drugs are required to mitigate the disease. A bibliographic search was carried out in SciELO and PubMed/Medline, 37 of 58 articles on the topic were selected. Objectives: Review and integrate the information on the pharmacokinetic interactions of azithromycin that are prescribed in the outpatient treatment of COVID-19 in Peru, and evaluate their clinical implication. Development: Azithromycin is used in COVID-19, due to its anti-inflammatory activity, by inhibiting interleukins (IL1, 6, 8 and TNF-α), and intracellular adhesion molecules 1 (ICAM1), and by inducing the production of type I interferon (IFN-α, IFN-β) and III (IFN-λ) in cells of patients with chronic obstructive pulmonary disease. The three-arm, randomized and open-label studies indicate that azithromycin does not cause changes in the pharmacokinetic parameters of ivermectin, sildenafil, rupatadine, and desloratadine, single-center, open-label, non-fasting, and two-period studies show that azithromycin influences the pharmacokinetic parameters of venetoclax and psychotropics. Conclusions: Based on the evidence from the reviewed and integrated clinical studies, it is concluded that these are limited and of little clinical relevance, however, it is proposed to use the antibiotic under the scientific criteria of the doctor, to avoid pharmacokinetic interactions and adverse reactions of drugs.

Translated title of the contributionPharmacokinetic interactions of azithromycin and clinical implication
Original languageSpanish
Article numbere02101284
JournalRevista Cubana de Medicina Militar
Volume50
Issue number3
StatePublished - 1 Jul 2021

Bibliographical note

Publisher Copyright:
© 2021, Editorial Ciencias Medicas. All rights reserved.

Fingerprint

Dive into the research topics of 'Pharmacokinetic interactions of azithromycin and clinical implication'. Together they form a unique fingerprint.

Cite this